ACTAFARMA

Actafarma is a self-care brand that the pharmaceutical laboratory Kern Pharma acquired in 2017.

This acquisition allowed Kern Pharma to reinforce its self-care formulary with leading products in the market such as Revidox®, Movial®, Oxicol® or Ceannum®, among others.

Currently, Kern Pharma operates in different areas of health: generics, biosimilars, women’s health, sports nutrition and self-care.

In this latter area and under its Kern Pharma Consumer line, the laboratory offers a wide range of its own self-care products as well as the Actafarma, Finisher and Gynea brands.

AWARDS

One of the 100 Best Ideas Award of 2009
The most innovative product Award of 2010 – Health Category
The most Innovative Company Award of 2010 in the Community of Madrid
The most innovative company Award in 2010
Gold Antenna Award 2016 in the Companies category
ACTAFARMA LABORATORIES | Actafarma
ACTAFARMA LABORATORIES | Actafarma
ACTAFARMA LABORATORIES | Actafarma
ACTAFARMA LABORATORIES | Actafarma